P

Inventor

GRIFFITHS GARY L

US64 patents
⚠️ This page may combine multiple inventors who share the name “GRIFFITHS GARY L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IMMUNOMEDICS INC

47 patents
US6962702B2Nov 8, 2005

Production and use of novel peptide-based agents for use with bi-specific antibodies

IMMUNOMEDICS INC126 citations99
US6077499AJun 20, 2000

Targeted combination immunotherapy of cancer

IMMUNOMEDICS INC304 citations99
US7011812B1Mar 14, 2006

Targeted combination immunotherapy of cancer and infectious diseases

IMMUNOMEDICS INC64 citations98
US5922302AJul 13, 1999

Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates

IMMUNOMEDICS INC165 citations98
US5736119AApr 7, 1998

Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates

IMMUNOMEDICS INC130 citations98
US5635603AJun 3, 1997

Preparation and use of immunoconjugates

IMMUNOMEDICS INC176 citations98
US5482698AJan 9, 1996

Detection and therapy of lesions with biotin/avidin polymer conjugates

IMMUNOMEDICS INC125 citations98
US7074405B1Jul 11, 2006

Use of bi-specific antibodies for pre-targeting diagnosis and therapy

IMMUNOMEDICS INC61 citations96
US7011816B2Mar 14, 2006

Labeling targeting agents with gallium-68 and gallium-67

IMMUNOMEDICS INC52 citations96
US6953567B2Oct 11, 2005

Fluorination of proteins and peptides for F-18 positron emission tomography

IMMUNOMEDICS INC52 citations96
US6558669B1May 6, 2003

Stable radioiodine conjugates and methods for their synthesis

IMMUNOMEDICS INC35 citations96
US6187284B1Feb 13, 2001

Fluorination of proteins and peptides for F-18 positron emission tomography

IMMUNOMEDICS INC62 citations96
US6126916AOct 3, 2000

Radiometal-binding peptide analogues

IMMUNOMEDICS INC51 citations96
US6120768ASep 19, 2000

Dota-biotin derivatives

IMMUNOMEDICS INC68 citations96
US6071490AJun 6, 2000

Position emission tomography using gallium-68 chelates

IMMUNOMEDICS INC70 citations96
US5753206AMay 19, 1998

Radiometal-binding analogues of luteinizing hormone releasing hormone

IMMUNOMEDICS INC70 citations96
US5670132ASep 23, 1997

Modified radioantibody fragments for reduced renal uptake

IMMUNOMEDICS INC95 citations96
US5128119AJul 7, 1992

Methods for technetium/rhenium labeling of f(ab1)2 fragments

IMMUNOMEDICS INC81 citations96
US7829064B2Nov 9, 2010

Anti-CD74 immunoconjugates and methods

IMMUNOMEDICS INC38 citations95
US5601825AFeb 11, 1997

Therapeutic conjugates of toxins and drugs

IMMUNOMEDICS INC65 citations95
US5541297AJul 30, 1996

Therapeutic conjugates of toxins and drugs

IMMUNOMEDICS INC52 citations95
US5328679AJul 12, 1994

Methods for technetium/rhenium labeling of proteins

IMMUNOMEDICS INC63 citations95
US6010680AJan 4, 2000

Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy

IMMUNOMEDICS INC50 citations94
US5772981AJun 30, 1998

Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy

IMMUNOMEDICS INC54 citations94
US8361464B2Jan 29, 2013

Anthracycline-Antibody Conjugates for Cancer Therapy

IMMUNOMEDICS INC18 citations93
US7429381B2Sep 30, 2008

Production and use of novel peptide-based agents for use with bi-specific antibodies

IMMUNOMEDICS INC14 citations93
US7300644B2Nov 27, 2007

Targeted combination immunotherapy

IMMUNOMEDICS INC25 citations93
US7052872B1May 30, 2006

Bi-specific antibodies for pre-targeting diagnosis and therapy

IMMUNOMEDICS INC49 citations93
US6576746B2Jun 10, 2003

Site-specific labeling of disulfide-containing targeting vectors

IMMUNOMEDICS INC40 citations93
US6361774B1Mar 26, 2002

Methods and compositions for increasing the target-specific toxicity of a chemotherapy drug

IMMUNOMEDICS INC40 citations93
US6358489B1Mar 19, 2002

Fluorination of proteins and peptides for F-18 positron emission tomography

IMMUNOMEDICS INC24 citations93
US5846741ADec 8, 1998

Boron neutron capture therapy using pre-targeting methods

IMMUNOMEDICS INC31 citations93
US8481003B2Jul 9, 2013

Anti-CD74 immunoconjugates and methods

IMMUNOMEDICS INC20 citations92
US5965131AOct 12, 1999

Delivery of diagnostic and therapeutic agents to a target site

IMMUNOMEDICS INC30 citations92
US5958408ASep 28, 1999

Delivery of diagnostic and therapeutic agents to a target site

IMMUNOMEDICS INC44 citations92
US5728369AMar 17, 1998

Radioactive phosphorus labeling of proteins for targeted radiotherapy

IMMUNOMEDICS INC25 citations92
US7230085B2Jun 12, 2007

Anti-DOTA antibody

IMMUNOMEDICS INC25 citations90
US5746996AMay 5, 1998

Thiolation of peptides for radionuclide-based radiodetection and radiotherapy

IMMUNOMEDICS INC46 citations90
US5612016AMar 18, 1997

Conjugates of antibodies and bifunctional ligands

IMMUNOMEDICS INC40 citations89
US8568729B2Oct 29, 2013

Anthracycline-antibody conjugates for cancer therapy

IMMUNOMEDICS INC7 citations84
US7833528B2Nov 16, 2010

Use of multispecific, non-covalent complexes for targeted delivery of therapeutics

IMMUNOMEDICS INC10 citations84
US7514066B2Apr 7, 2009

Targeted combination immunotherapy of cancer and infectious diseases

IMMUNOMEDICS INC10 citations84
US7045503B1May 16, 2006

Radiometal-binding peptide analogues

IMMUNOMEDICS INC14 citations84
US8343496B2Jan 1, 2013

Anti-CD74 immunoconjugates and methods

IMMUNOMEDICS INC8 citations83
US7931890B2Apr 26, 2011

Targeted combination immunotherapy of cancer and infectious diseases

IMMUNOMEDICS INC5 citations74
US7259249B2Aug 21, 2007

Method for preparing conjugates of proteins and chelating agents

IMMUNOMEDICS INC7 citations74
US5976492ANov 2, 1999

Radioactive phosphorus labeled proteins for targeted radiotherapy

IMMUNOMEDICS INC11 citations73

KNUTSON JAY R

1 patent

(unassigned)

1 patent

US HEALTH

1 patent

Showing the top 50 of 64 patents by PatentIndex Score.